This is why Ra Pharmaceuticals, Inc. (RARX) share price is gaining 3.6% today

Ra Pharmaceuticals, Inc. (NASDAQ:RARX) is 0.83 points higher today and the only thing that matters is where they go from here. You simply have to look deeper than the share price and explore the fundamentals and future growth potential. The stock value has climbed by nearly 3.6% to $23.86 from its previous close of $23.03. Does this growth mean it the best stock to buy right now? The shares seem to have an active trading volume day with a reported 206704 contracts so far this session. RARX shares had a relatively better volume day versus average trading capacity of 439.42 thousand shares, but with a 40.3 million float and a 10.77% run over a week, it’s definitely worth keeping an eye on. The one year price forecast for RARX stock indicates that the average analyst price target is $38 per share. This means the stock has a potential increase of 59.26% from where the RARX share price has been trading recently which is between $22.8 and $24. There are some brokerage firms that offer lower targets than the average, with one of them, even setting their price target at $32. The shorts are running away from Ra Pharmaceuticals, Inc. (RARX) stock. The latest set of short interest data was released on 15 March 2019, and the numbers show a drop in short interest in RARX shares. While short interest still represents only 3.71% of RARX’s float, the number of shares shorted have fallen by -162143. The number of shares shorted fell to 1496865 shares, down from 1659008 shares during the preceding fortnight. With average daily trading volumes at 814625 shares, days to cover decreased to about 4.686702 days. The most recent news story about the stock that appeared in Yahoo Finance‘s news section was titled “Ra Pharmaceuticals Announces Completion of End-of-Phase 2 Interactions with FDA and Design of Pivotal Phase 3 gMG Study” and dated April 09, 2019.